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ABSTRACT
Objective To ascertain the risk of acute myocardial
infarction, invasive cardiac procedures, and mortality
among patients with newly diagnosed angina over five
years.
Design Incident cohort study of patients with primary care
data linked to secondary care and mortality data.
Setting 40 primary care practices in Scotland.
Participants 1785 patients with a diagnosis of angina as
their first manifestation of ischaemic heart disease, 1
January 1998 to 31 December 2001.
Main outcomemeasures Adjusted hazard ratios for acute
myocardial infarction, coronary artery bypass grafting,
percutaneous transluminal coronary angioplasty, death
from ischaemic heart disease, and all cause mortality,
adjusted for demographics, lifestyle risk factors, and
comorbidity at cohort entry.
ResultsMean age was 62.3 (SD 11.3). Male sex was
associated with an increased risk of acute myocardial
infarction (hazard ratio 2.01, 95% confidence interval
1.35 to 2.97), death from ischaemic heart disease (2.80,
1.73 to 4.53), and all causemortality (1.82, 1.33 to 2.49).
Increasing age was associated with acute myocardial
infarction (1.04, 1.02 to 1.06, per year of age increase),
death from ischaemic heart disease (1.09, 1.06 to 1.11,
per year of age increase), and all cause mortality (1.09,
1.07 to 1.11, per year of age increase). Smoking was
associated with subsequent acute myocardial infarction
(1.94, 1.31 to 2.89), death from ischaemic heart disease
(2.12, 1.32 to 3.39), and all causemortality (2.11, 1.52 to
2.95). Obesity was associated with death from ischaemic
heart disease (2.01, 1.17 to 3.45) and all cause mortality
(2.20, 1.52 to 3.19). Previous stroke was associated with
all causemortality (1.78, 1.13 to 2.80) and chronic kidney
disease with death from ischaemic heart disease (5.72,
1.74 to 18.79). Men were more likely than women to have
coronary artery bypass grafting or percutaneous
transluminal coronary angioplasty after a diagnosis of
angina; older people were less likely to receive
percutaneous transluminal coronary angioplasty. Acute
myocardial infarction after a diagnosis of angina was
associatedwith an increased risk of death from ischaemic
heart disease and all cause mortality (8.84 (5.31 to
14.71) and 4.23 (2.78 to 6.43), respectively). Neither of
the invasive cardiac procedures significantly reduced the
subsequent risk of all cause mortality.
Conclusions In this sample of people with incident angina
from primary care, there were sex differences in survival
and age and sex differences in the provision of
revascularisation after a diagnosis. Acute myocardial
infarction after a diagnosis of angina was strongly
predictive of mortality. To minimise adverse outcomes,
optimal preventive treatments should be used in patients
with angina.
INTRODUCTION
In theUnitedKingdom, angina is common and is often
the first manifestation of ischaemic heart disease.
Recent prevalence estimates based on the Rose angina
questionnaire suggest that 4.8% of men and 3.4% of
women aged over 16 in England have the condition,1
while in Scotland angina diagnosed by a doctor is
reported to occur in 6.6% and 5.6%, respectively.2
Understanding the risk of acute myocardial infarction,
invasive cardiac procedures, and death after a diagno-
sis of angina is important for patients and their clini-
cians, especially those working in primary care,
wheremost cases of angina are first detected.Most pre-
vious studies of the prognostic importance of angina
have examined populations identified from secondary
or tertiary care settings. Descriptions of prognosis
derived from such settings might be misleading in
management of patients in primary care. The referral
process might introduce important selection biases
that could affect our understanding of the prognosis
of people identified in primary care. Others have
already shown that patients entered into hospital
based trials of blood pressure control after stroke
have important differences in age, sex, and blood pres-
sure compared with patients managed in the commu-
nity after their stroke.3 The Renfrew-Paisley
epidemiological study offered valuable insights into
prognosis among a population derived sample of peo-
ple with possible angina as identified by the Rose
angina questionnaire: compared with men, women
had a reduced risk of death from any cardiovascular
cause, ischaemic heart disease, or acute myocardial
infarction and a reduced risk of admission to hospital
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for any of these indications.4 The cohort was of preva-
lent rather than incident cases, recruited only people
aged 45-64 at entry, and included those with pre-exist-
ing angina and other ischaemic heart disease.
So far the fewprognostic studies of angina in primary
care are of limited value because they are compara-
tively old, included small numbers, or were of poor
quality, leading researchers to comment that more stu-
dies are still needed.5-7We examined the risk of several
cardiac outcomes (acute myocardial infarction, inva-
sive cardiac procedures, and death) during the first
five years after a first diagnosis of angina in a popula-
tion identified from primary care in Scotland.
METHODS
Sampling frame
The sampling frame for the studywas all patients regis-
tered with 40 practices in Scotland. The practices have
been participating in the practice team information
project operated by the information services division
of the NHS in Scotland and contributing data to the
primary care clinical informatics unit at the University
of Aberdeen.8 In May 2007 the primary care patient
data were linked with deprivation score (Scottish
index of multiple deprivation9), secondary care data
held on the Scottish morbidity record (SMR01) data-
bases housed by the information services division, and
cause of death data, which is collected by the general
register office for Scotland (GROS) and routinely
linked to the Scottishmorbidity record by the informa-
tion services division, to create a novel linked research
database. The patients within the linked database are
broadly representative of the Scottish population with
respect to age, sex, and social deprivation.10
Incident sample
From the linkeddatabasewe identified everyonewith a
diagnosis of angina pectoris (Read codesG311, G33 to
G330z, G33z-G33zz, Gyu30) for the first time between
1 January 1998 and31December 2001.Thiswas desig-
nated as the index episode. For as long as the identified
patients were alive we checked each general practice
electronic record for any record of ischaemic heart dis-
ease (Read codeG3 toG330z,G33z toG3401,G342 to
G366, G38 to G3z, Gyu3), atrial fibrillation (G573,
G5730 to G573z, 212R), or heart failure (G58, G580,
G5800 to G5803, G581, G5810, G582, G1yz1) before
the date of the index episode.We also checked the sec-
ondary care information for each person to see
whether there was a diagnosis of ischaemic heart dis-
ease (ICD-9 (international classification of diseases,
ninth revision) codes 410 to 414 (1981-96) and ICD-
10 codes I20 to I22, I24 to I25, I42, I46, I50 (1997
onwards)) back to 1981, when reliable SMR01 records
began. We excluded individuals with a relevant pri-
mary or secondary care diagnosis recorded before
the index episode. Those without such a record were
deemed to have experienced an incident (first ever)
episode of angina on the index date.
The general practice computer records of incident
cases were examined for the presence of “baseline”
comorbidities, which were determined a priori as
being related to outcome: diabetes (Read code C10
and below), peripheral vascular disease (Read code
G73 and below), chronic kidney disease (14D, 14D1,
14V2, 1Z1,1Z10, 1Z11, 1Z1-4, 7B063, 7L1A-B, 8L50,
G22, G220-z, G232-3, G701, G703, K05, K050, K0D,
K07, K070-z, PD1, PD11-z, D215, ZV560, K0B,
K0B1-6, K09, K090-1, K09z, K0C, K0C0-4, D3101,
K03, K031-2, K06, K138z, P7690, TA020, ZV451),
stroke (G65 to G654, G656 to G65zz, G61 below but
not G617, G66 and below, G63y0-1, G6760, G6w,
G6x, G64 and below), and hypertension (G2, G20
and below, G24 to G2z).We also examined the cohort
for previous or subsequent recording of undefined
chest pain (Read code 182 and below; not 1821) or
receipt of an angina related prescription (antiplatelet,
β blocker, or nitrate). Each conditionwas recorded as a
separate dichotomous variable. Similarly, the presence
or absenceof cardiovascular risk factors (current smok-
ing (1372-1376, 137C-137D, 137G-137H, 137J, 137M,
137P-137R, 137V, 137X-137f, 137h) and being obese
(defined as body mass index >30) before or after the
date of the index episode of angina was ascertained by
using the information closest to that date.We excluded
those in whom smoking status and body mass index
(BMI) were not recorded to avoid the effect of report-
ing bias in the analysis. The postcode of each patient
was used to assign a deprivation status on a 10 point
scale, which was then converted to fifths for analysis
(1=most affluent to 5=most deprived) based on the
Scottish index of multiple deprivation, which uses 37
indicators of poverty across seven domains (current
income, employment, health, education, housing, geo-
graphical access, and crime).9
Follow-up
Each patient was followed up to the event of interest,
death, or for five years (1826 days) from the date of the
index episode of angina, whichever came first. All out-
come data were retrieved from the SMR01 secondary
care records and GROS mortality records. The out-
comemeasures were an SMR01 record for acute myo-
cardial infarction (ICD-10 codes I21-I22),
revascularisation by coronary artery bypass grafting
(operation and procedures coding system 4 codes
K40-5), percutaneous transluminal coronary angio-
plasty with or without stents (K49, K501, K508-9), a
GROS record of death from ischaemic heart disease
(ICD-9 codes 410-4 (used by GROS for deaths before
2000) and ICD-10 codes (for year 2000 onwards) I20-
25, I42, I46, I50), and death from any cause.
Statistical analysis
We used Student’s t tests and χ2 tests to compare con-
tinuous and categorical variables in different groups.
Survival analysis was conducted to investigate the
effect of different baseline characteristics on the time
to the different outcomes. Cox proportional hazards
models were initially fitted separately for each baseline
characteristic to determine their individual effect. Full
models were then fitted to calculate hazard ratios for
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each baseline variable with adjustment for other con-
founding variables. For outcomes of acute myocardial
infarction, coronary artery bypass grafting, and percu-
taneous transluminal coronary angioplasty we cen-
sored patients at death or at five years after entry,
whichever came first. For all cause mortality patients
were censored at five years after entry, whereas for
mortality from ischaemic heart disease, patients were
censored at the time of other causes of death or at five
years after entry. Survival analyses of time to acute
myocardial infarction, percutaneous transluminal cor-
onary angioplasty, coronary artery bypass grafting,
death from ischaemic heart disease, and all cause mor-
tality were adjusted for sex, age, deprivation, smoking,
obesity, and comorbidity at baseline.Weexamined the
effect on future risk of death of having an acute myo-
cardial infarction or a cardiac procedure, or both, after
the index diagnosis by including these variables as
additional time varying covariates in an extension of
the adjusted mortality analyses. We checked assump-
tions of proportional hazards using various diagnostic
plots. Kaplan-Meier curves displayed the probability
of survival over the study period among men and
women of different ages. Analysis was conducted
with SPSS version 15.0 (SPSS, Chicago, IL) and SAS
(v9) software package (SAS Institute, Cary, NC).
RESULTS
Among the 40 practices, 6676 patients had angina pec-
toris recorded between 1 January 1998 and 31Decem-
ber 2001. Checks of their records before the index
episode found that 4609 of the patients had a previous
general practice record of atrial fibrillation, heart fail-
ure, diagnosis of ischaemic heart disease, or a hospital
admission related to ischaemic heart disease. A further
282 had incomplete data on smoking or BMI. Thus,
1785 patients were deemed to have had a first episode
of angina as a first manifestation of ischaemic heart dis-
ease and had complete data.Of these, 326patients (157
women) had a general practice record of undefined
chest pain before the index episode of angina. Five
hundred and eighty four patients (296 women) had
chest pain recorded after their index angina episode;
482 (82.5%) also had a subsequent general practice
record of angina (246 women) and 538 (92.1%) had a
subsequent record of an ischaemic heart disease condi-
tion (273 women). Forty six patients had a record of
unspecified chest pain but no specific coding for
ischaemic heart disease after entry into the cohort. Of
these, 33 received prescriptions for angina related
drugs (nitrates, β blockers, or antiplatelets), six (0.3%
of the cohort) died without any subsequent treatment
for ischaemic heart disease during follow-up, and
seven (0.4%)who lived beyond five years werewithout
any codes for ischaemic heart disease or prescribing
data related to angina after the initial diagnosis.
Some patients had more than one angina Read code
recorded.Nearly all codes had the descriptor of angina
pectoris: G33 (angina pectoris: n=1355), G33zz
(angina pectoris: n=861), G33z (angina pectoris:
n=53). Smaller numbers had G311 (preinfarction
syndrome: n=115), G3300 (nocturnal angina: n=1),
G331 (Prinzmetal’s angina: n=2), G332 (coronary
artery spasm: n=1), G33z1 (stenocardia: n=1), G33z3
(angina on effort: n=14), G33z4 (ischaemic chest pain:
n=3), G33z6 (new onset angina: n=1), and G33z7
(stable angina: n=1). Although we did not include
unstable angina in our entry criteria, a subsequent
search found only one patient with this condition
recorded simultaneously with a code of G33 (angina
pectoris).
The cohort included 846 (47.4%) women and 939
(52.6%) men (table 1). The mean age at cohort entry
was 62.3 (SD 11.3). Women were significantly older
than men (mean age at entry 63.6 (SD 11.3) v 61.2
(SD 11.2); t=4.4; P<0.001) and were more likely to
have hypertension and be obese, while men were
more likely to have had a previous stroke (table 1).
Within the five years’ follow-up, 152 (8.5%) patients
underwent coronary artery bypass grafting, 108 (6.1%)
underwent percutaneous transluminal coronary angio-
plasty, 116 (6.5%) had an acute myocardial infarction,
84 (4.8%) died from ischaemic heart disease, and 175
(9.8%) died from any cause. All of the events were
more common inmen thanwomen. A fairly consistent
pattern emerged of events occurring more often
among individuals with a history of comorbidity,
although many of the differences were not significant.
Hazard ratios adjusted for potential confounding
factors indicated that the likelihood of having a coron-
ary procedure remained significantly higher in men
than in women even after we allowed for differences
in the baseline characteristics (table 2). Older age was
associatedwith a reduced likelihood of having a percu-
taneous transluminal coronary angioplasty. None of
the other baseline characteristicswas significantly asso-
ciated with likelihood of receiving either cardiac pro-
cedure. In those patients who received the procedures,
the median (interquartile range) times to coronary
artery bypass grafting and percutaneous transluminal
coronary angioplasty were 436.5 (201.0-836.5) days
and 218.5 (78.5-508.0) days, respectively.
Male sex, older age, and smoking were associated
with an increased likelihood of having an acute myo-
cardial infarction (table 3). In those patients who
Table 1 | Number (percentage) of women and men in cohort
with history of comorbidity and cardiovascular risk factors at
baseline
Total
(n=1785)
Women
(n=846)
Men
(n=939) P value
Comorbidity:
Diabetes 185 (10.4) 78 (9.2) 107 (11.4) 0.132
Previous stroke 119 (6.7) 40 (4.7) 79 (8.4) 0.002
PVD 109 (6.1) 44 (5.2) 65 (6.9) 0.129
Hypertension 592 (33.2) 324 (38.3) 268 (28.5) <0.001
CKD 14 (0.8) 7 (0.8) 7 (0.7) 0.845
Current smoker 618 (34.6) 275 (32.5) 343 (36.5) 0.074
Obese 338 (18.9) 179 (21.2) 159 (16.9) 0.023
PVD=peripheral vascular disease; CKD=chronic kidney disease.
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experienced an acute myocardial infarction during the
study period, the median (interquartile range) time to
event was 225.5 (7.0-750.0) days.
Male sex, older age, smoking and obesity were each
associated with a significant increased risk of death
from ischaemic heart disease or any cause (table 4).
The figure shows Kaplan-Meier curves for all cause
mortality in men and women stratified by age (<65,
65-74, ≥75). After adjustment for baseline characteris-
tics, a history of chronic kidney disease before the
index episode was associated with an increased risk
of death from ischaemic heart disease, and history of
strokewith all causemortality. Among thosewho died,
the median (interquartile range) time to death from
ischaemic heart disease was 842.5 (417.0-1179.0)
days and to any death 771.0 (417.0-1193.0) days.
As an extension to the adjustedmortalitymodels, we
included cardiac procedures and acute myocardial
infarction after the indexdiagnosis as timevarying cov-
ariates. We found significant hazard ratios associating
acute myocardial infarction after a diagnosis of angina
with an increased likelihood of subsequent death from
ischaemic heart disease (8.84, 95% confidence interval
5.31 to 14.71) and all cause mortality (4.23, 2.78 to
6.43). The hazard ratio associatedwith coronary artery
bypass grafting after index diagnosis was 0.49 (0.25 to
1.95) for death from ischaemic heart disease and 0.58
(0.25 to 1.32) for all cause mortality. The correspond-
ing figures for percutaneous transluminal coronary
angioplasty after index diagnosis were 0.45 (0.13
to1.52) and 0.55 (0.22 to 1.38), respectively.
To minimise the risk of reporting bias, we excluded
from the incident angina cohort those with baseline
data missing on smoking and BMI. While the sex pro-
file of excluded patients was similar to that of included
patients (51.3% v 52.6% men and 48.7% v 47.4%
women), those excluded were substantially older
(mean age 73.8 (SD 12.6) v 62.3 (SD 11.3)). Inclusion
of individuals with missing data, however, produced
similar patterns of association to those presented.
DISCUSSION
Several baseline characteristics in people with a first
diagnosis of angina are associated with subsequent
risk of a number of cardiac outcomes. These
Table 2 | Proportions and unadjusted and adjusted hazard ratios for coronary procedures by baseline characteristics
Baseline characteristic
Coronary artery bypass grafting Percutaneous transluminal coronary angioplasty
No (%)
Hazard ratio (95% CI)
No (%)
Hazard ratio (95% CI)
Unadjusted Adjusted Unadjusted Adjusted
Men (v women†) 117 (12.5) 3.23 (2.22 to 4.71)*** 3.11 (2.12 to 4.56)*** 71 (7.6) 1.80 (1.21 to 2.67)** 1.58 (1.05 to 2.36)*
Increasing age (per year) 62 (54-67)‡ 0.99 (0.97 to 0.999)* 0.99 (0.97 to 1.00) 60 (50-66)‡ 0.97 (0.95 to 0.98)*** 0.97 (0.95 to 0.98)***
Deprivation fifth (v 1st)§:
2nd 29 (8.7) 0.75 (0.44 to 1.29) 0.86 (0.50 to 1.47) 19 (5.7) 0.74 (0.38 to 1.43) 0.79 (0.41 to 1.55)
3rd 38 (8.6) 0.75 (0.45 to 1.25) 0.82 (0.49 to 1.38) 28 (6.4) 0.82 (0.45 to 1.52) 0.86 (0.47 to 1.60)
4th 34 (8.3) 0.73 (0.43 to 1.23) 0.75 (0.44 to 1.27) 27 (6.6) 0.86 (0.46 to 1.60) 0.80 (0.43 to 1.50)
5th 27 (6.9) 0.60 (0.35 to 1.04) 0.66 (0.38 to 1.16) 18 (4.6) 0.60 (0.31 to 1.18) 0.56 (0.28 to 1.11)
Comorbidity (yes v no):
Diabetes 21 (11.4) 1.39 (0.88 to 2.20) 1.28 (0.79 to 2.06) 15 (8.1) 1.41 (0.82 to 2.43) 1.48 (0.84 to 2.59)
CKD 2 (14.3) 1.70 (0.42 to 6.85) 1.58 (0.39 to 6.43) 1 (7.1) 1.16 (0.16 to 8.34) 1.19 (0.17 to 8.59)
Stroke 10 (8.4) 1.04 (0.55 to 1.98) 0.86 (0.45 to 1.66) 7 (5.9) 1.00 (0.46 to 2.15) 1.11 (0.51 to 2.43)
PVD 13 (11.9) 1.46 (0.82 to 2.57) 1.38 (0.77 to 2.49) 6 (5.5) 0.90 (0.40 to 2.05) 0.99 (0.43 to 2.29)
Hypertension 56 (9.5) 1.20 (0.86 to 1.66) 1.40 (0.99 to 1.98) 31 (5.2) 0.81 (0.53 to 1.23) 0.92 (0.60 to 1.42)
Smoker (yes v no) 57 (9.2) 1.15 (0.83 to 1.60) 1.12 (0.79 to 1.60) 43 (7.0) 1.28 (0.87 to 1.88) 1.07 (0.70 to 1.61)
Obese (yes v no) 22 (6.5) 0.73 (0.47 to 1.15) 0.71 (0.45 to 1.13) 18 (5.3) 0.87 (0.52 to 1.44) 0.76 (0.45 to 1.28)
CKD=chronic kidney disease; PVD=peripheral vascular disease.
*P<0.05; **P<0.01; ***P<0.001.
†35 (4.1%) women had coronary artery bypass grafting and 37 (4.4%) had percutaneous transluminal coronary angioplasty.
‡Median (interquartile range) ages of outcome
§In first fifth of deprivation 24 (11.4%) had coronary artery bypass grafting and 16 (7.6%) had percutaneous transluminal coronary angioplasty.
Table 3 | Proportions and unadjusted and adjusted hazard ratios for acute myocardial
infarction by baseline characteristics
Baseline characteristic No (%)
Hazard ratio (95% CI)
Unadjusted Adjusted
Men (v women†) 77 (8.2) 1.85 (1.26 to 2.72)** 2.01 (1.35 to 2.97)***
Increasing age (per year) 66 (57-73)‡ 1.02 (1.01 to 1.04)** 1.04 (1.02 to 1.06)***
Deprivation fifth (v 1st)§:
2nd 25 (7.5) 1.30 (0.65 to 2.58) 1.25 (0.63 to 2.49)
3rd 34 (7.7) 1.36 (0.70 to 2.63) 1.35 (0.70 to 2.62)
4th 15 (3.7) 0.63 (0.30 to 1.35) 0.61 (0.29 to 1.32)
5th 30 (7.7) 1.36 (0.70 to 2.65) 1.29 (0.65 to 2.55)
Comorbidity (yes v no):
Diabetes 13 (7.0) 1.08 (0.61 to 1.93) 1.06 (0.59 to 1.92)
CKD 1 (7.1) 1.09 (0.15 to 7.79) 1.32 (0.18 to 9.59)
Stroke 8 (6.7) 1.07 (0.52 to 2.19) 0.91 (0.44 to 1.90)
PVD 9 (8.3) 1.30 (0.66 to 2.56) 1.01 (0.50 to 2.01)
Hypertension 36 (6.1) 0.90 (0.61 to 1.34) 0.92 (0.61 to 1.38)
Smoker (yes v no) 51 (8.3) 1.52 (1.05 to 2.19)* 1.94 (1.31 to 2.89)**
Obese (yes v no) 25 (7.4) 1.20 (0.77 to 1.86) 1.45 (0.91 to 2.30)
CKD=chronic kidney disease; PVD=peripheral vascular disease.
*P<0.05; **P<0.01; ***P<0.001.
†39 (4.6%) women had diagnosis of acute myocardial infarction.
‡Median (interquartile range) ages of outcome.
§In first fifth of deprivation 12 (5.7%) patients had diagnosis of acute myocardial infarction.
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characteristics include (depending on outcome exam-
ined) male sex, age, smoking, obesity, and previous
stroke or chronic kidney disease. An acute myocardial
infarction after the index episode of angina greatly
increased the risk of subsequent death. Although
there was a suggestion that both coronary artery
bypass grafting and percutaneous transluminal coron-
ary angioplasty after a diagnosis of angina might
reduce the subsequent risk of death from ischaemic
heart disease or all cause mortality, none of the risk
estimates reached significance.
Results in the context of other recent angina cohorts
Within the spectrumof ischaemic heart disease, angina
in primary care has received insufficient attention.6 7
Previous studies of prognostic risk after a diagnosis of
angina have had several important limitations: use of
selected populations, often from secondary or tertiary
care; lack of longitudinal data from an early stage of
disease; different criteria used to define, diagnose, or
report angina; and incomplete information about a
range of outcomes, such as acute myocardial infarc-
tion, coronary artery bypass grafting, percutaneous
transluminal coronary angioplasty, or mortality.7
Many studies have examined prevalent groups of indi-
viduals, often established through a cross sectional
study that identifies everyone with angina in a given
population at a particular point in time, rather than
incident groups established by the identification of
new cases over a period of time. Prevalent cohorts
will include individuals at different stages of disease,
including a proportion of individuals who have had
angina for some time. Studies of such cohorts might
underestimate survival after a first diagnosis of angina.
Strengths and implications
A major strength of our study was the use of a large
incident cohort of patients identified in primary care
and thus not prone to the selection biases that can
occur through the referral process. Other strengths
were the relatively long follow-up, the availability of
Table 4 | Proportions and unadjusted and adjusted hazard ratios for mortality by baseline characteristics
Baseline characteristic
Ischaemic heart disease mortality All cause mortality
No (%)
Hazard ratio (95% CI)
No (%)
Hazard ratio (95% CI)
Unadjusted Adjusted Unadjusted Adjusted
Men (v women†) 62 (6.6) 2.40 (1.50 to 3.85)*** 2.80 (1.73 to 4.53)*** 110 (11.7) 1.57 (1.16 to 2.14)** 1.82 (1.33 to 2.49)***
Increasing age (per year) 71.5(62-77)‡ 1.07 (1.04 to 1.09)*** 1.09 (1.06 to 1.11)*** 71 (61-77)‡ 1.07 (1.05 to 1.09)*** 1.09 (1.07 to 1.11)***
Deprivation fifth (v 1st)§:
2nd 15 (4.5) 1.57 (0.61 to 4.05) 1.41 (0.54 to 3.66) 33 (9.9) 1.09 (0.62 to 1.92) 0.97 (0.55 to 1.71)
3rd 19 (4.3) 1.51 (0.60 to 3.78) 1.50 (0.60 to 3.78) 40 (9.1) 1.00 (0.58 to 1.73) 0.96 (0.56 to 1.67)
4th 25 (6.1) 2.17 (0.89 to 5.28) 2.22 (0.91 to 5.45) 44 (10.8) 1.20 (0.70 to 2.06) 1.22 (0.71 to 2.10)
5th 21 (5.4) 1.90 (0.77 to 4.72) 1.91 (0.76 to 4.79) 39 (10.0) 1.12 (0.65 to 1.93) 1.08 (0.62 to 1.89)
Comorbidity (yes v no):
Diabetes 10 (5.4) 1.13 (0.59 to 2.19) 0.97 (0.49 to 1.91) 19 (10.3) 1.05 (0.65 to 1.69) 0.92 (0.57 to 1.50)
CKD 3 (21.4) 4.81 (1.52 to 15.21)** 5.72 (1.74 to 18.79)** 3 (21.4) 2.32 (0.74 to 7.28) 2.82 (0.88 to 8.98)
Stroke 12 (10.1) 2.43 (1.32 to 4.48)** 1.80 (0.96 to 3.38) 23 (19.3) 2.28 (1.47 to 3.53)*** 1.78 (1.13 to 2.80)*
PVD 8 (7.3) 1.59 (0.77 to 3.30) 0.85 (0.40 to 1.79) 17 (15.6) 1.67 (1.02 to 2.76)* 1.01 (0.60 to 1.68)
Hypertension 30 (5.1) 1.09 (0.70 to 1.70) 1.01 (0.63 to 1.61) 59 (10.0) 1.03 (0.76 to 1.41) 0.91 (0.66 to 1.27)
Smoker (yes v no) 34 (5.5) 1.26 (0.82 to 1.94) 2.12 (1.32 to 3.39)** 67 (10.8) 1.19 (0.88 to 1.62) 2.11 (1.52 to 2.95)***
Obese (yes v no) 19 (5.6) 1.24 (0.75 to 2.07) 2.01 (1.17 to 3.45)* 41 (12.1) 1.34 (0.95 to 1.90) 2.20 (1.52 to 3.19)***
CKD=chronic kidney disease; PVD=peripheral vascular disease.
*P<0.05; **P<0.01; ***P<0.001.
†24 (2.8%) women died from coronary heart disease and 65 (7.7%) died from any cause.
‡Median (interquartile range) ages of outcome.
§ In first fifth of deprivation 6 (2.9%) died from coronary heart disease and 19 (9.1%) from any cause.
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groups was highly significant for both men and women
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data on several characteristics of individuals before the
index diagnosis, and the novel database linkage, which
allowed the use of data recorded in secondary aswell as
primary care and data on cause of death from the gen-
eral register office for Scotland. The use of outcome
data from secondary care and the general register
office allowed follow-up even when individuals left
the practice where the index diagnosis was recorded.
The case finding method used seems robust: of the
patients included in the cohort because of a first record
of angina, fewer than 1% had no subsequent record of
angina, another ischaemic heart disease diagnosis, or
treatment related to angina.
In comparison with a cohort of patients with angina
identified from secondary care cardiology clinics for
the large Euro Heart cohort,11 our cohort was slightly
older (62.3 v 61.0) and had proportionally fewer men
(52.6% v 58.0%). Our comorbidity profile was also dif-
ferent (for example, 33% inour studyhadhypertension
and 10% had diabetes compared with 62% and 18%,
respectively, in the Euro Heart study). Another large
global cohort of patients with stable angina from a car-
diac clinic (theACTIONtrial), whichhas subsequently
been used to calculate an angina risk score, had a high
proportion of men (79.4%).12 These differences
emphasise the need to be cautious when extrapolating
findings from secondary to primary care, for instance
when developing risk scores or guidelines.
We identified strong significant associations
between male sex and subsequent acute myocardial
infarction, death from ischaemic heart disease, and all
causemortality.Male sex was not identified as a signif-
icant predictor of acute myocardial infarction or death
in either the ACTION or Euro Heart secondary care
populations.11 12 The Renfrew-Paisley population
based study also found that, compared with women,
men had a higher likelihood of morbidity and mortal-
ity related to ischaemic heart disease.4
In our study smoking was significantly associated
with an increased risk of subsequent acute myocardial
infarction, death from ischaemic heart disease, and all
cause mortality, supporting the findings derived from
the ACTION trial cohort. We also found a significant
association between obesity and mortality but not
between obesity and subsequent acute myocardial
infarction. Obesity was not included as a risk factor in
the ACTION or Euro Heart studies. In line with the
ACTIONcohort, we identified an association between
stroke and all cause death. The association in our study
between chronic kidney disease anddeath from ischae-
mic heart disease in patients with angina was based on
only three deaths, using Read codes for diagnoses of
chronic kidney disease rather than calculations from
estimated glomerular filtration rates. Nevertheless it
is in line with findings from a recent Irish primary
care cohort of people with ischaemic heart disease.13
We found that male sex was associated with an
increased likelihood of receiving either coronary
artery bypass grafting or percutaneous transluminal
coronary angioplasty after index diagnosis. Other stu-
dies have shown sex based differences in service
provision for cardiac patients.14 15 The different sex
profile of our primary care cohort compared with the
secondary care basedACTIONand EuroHeart popu-
lations might also indicate that more men than women
diagnosed with angina are referred to secondary care,
resulting in women being more likely to be managed
solely in primary care.
A clinical implication highlighted by our study was
the importance of preventing a subsequent acute myo-
cardial infarction in patients diagnosed with angina.
When included in the mortality models as a time vary-
ing covariate, acute myocardial infarction was asso-
ciated with a large hazard ratio for both death from
ischaemic heart disease and all cause mortality. These
results suggest that appropriate control of risk factors
and optimal use of preventive medical treatments
should be aggressively pursued in patientswith angina.
It is interesting that in this incident cohort of people
with a first diagnosis of angina derived from primary
care, neither coronary artery bypass grafting nor per-
cutaneous transluminal coronary angioplastywas asso-
ciated with significantly improved survival. It must be
borne in mind that the findings relating to these inter-
ventions were based on a relatively small amount of
data and thus might have lacked statistical power. In
addition, the observational results might have been
affected by unmeasured confounding. Yet, current evi-
dence suggests these interventions do not confer the
same survival benefits for all patients with ischaemic
heart disease.16-20 Much of the literature is compara-
tively old and considered populations that were
younger than those in our primary care cohort, predo-
minantly men, and included patients with previous
acute myocardial infarction as well as those with
angina alone. Meta-analyses suggest that coronary
artery bypass grafting principally benefits those with
more severe ischaemic heart disease, two or three ves-
sel disease, and left main artery disease, with no signif-
icant survival benefit in those with one or two vessel
disease or low risk profile.17 19 20 A more recent study
has suggested that in older patients with angina, opti-
mal medical treatment confers benefits similar to cor-
onary artery bypass grafting.18 While the benefit
associated with percutaneous transluminal coronary
angioplasty in patients with acute coronary syndromes
is established, its value in patients without these pro-
blems is less certain.16 Our results relating to percuta-
neous transluminal coronary angioplasty are in line
with those from the recent COURAGE trial, which
reported no significant difference in mortality or sub-
sequent acute myocardial infarction when percuta-
neous transluminal coronary angioplasty plus
optimalmedical treatmentwas comparedwith optimal
medical treatment alone among 2287 people with
stable coronary artery disease (78% of whom had
angina at baseline) during a median follow-up of 4.
6 years.21 A UK historical cohort study found that in
contemporary routine clinical practice survival from
death is similar after either coronary artery bypass
grafting or percutaneous revascularisation.22 A recent
Cochrane review of percutaneous transluminal
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coronary angioplasty with stents compared with cor-
onary artery bypass grafting found no significant dif-
ference for subsequent acute myocardial infarction or
mortality between the interventions in patients with
stable angina or acute coronary syndromes.23 Research
has highlighted the need for further prognostic
research in representative, real world populations of
people with angina; such research might identify sub-
groups that benefit most from particular inter
ventions.23 24 Experimental studies such as large scale
randomised clinical trials with prolonged follow-up
might establish the effectiveness of such strategies
while avoiding confounding issues.
Study limitations
Our study has several limitations. We studied only
individuals who had a recorded diagnosis of angina
on their general practice records. We are therefore
unable to say anything about the prognosis of indivi-
duals with angina whose condition remains undiag-
nosed in the community.25 Others have already
shown that womenwith previously unrecorded angina
have an increased risk of death compared with those
without such a history.26We did not have any details of
the criteria used by the general practitioners when
recording an episode of angina or of any investigations
used to make the diagnosis. It is possible that different
criteria were used for different groups within the popu-
lation, although the strong relation between diagnosis
of angina, baseline characteristics, and risk of cardiac
outcomes provides face validity for the index diagno-
sis. The introduction of the quality and outcomes fra-
mework for general practice in the UK in 2004 has
resulted in increased referral of patients presenting
with angina for diagnostic tests such as
angiography.27 This will provide new opportunities to
determine whether estimates of prognosis change with
certainty of diagnosis, although it will be several more
years before such work can be undertaken with
reasonable statistical precision. Although we were
able to control for several important factors recorded
at baseline, we did not control for treatments after diag-
nosis because data were not available about contrain-
dications, severity of illness, and patients’ preferences
or adherence to treatments, all of which contribute to
prescribing patterns and prognostic risk. Residual con-
founding, therefore, could explain some of our find-
ings. We have already shown important differences
between groups in the management of angina. For
example, we have found a greater use of prophylactic
treatments in younger people with angina,14 which
might explain our finding here of a decreased risk of
invasive cardiac procedures and increased risk of acute
myocardial infarction and mortality with age. On the
other hand, our previous finding that men are more
likely than women to be given active treatment for
their angina14 would not explain the greater risk of all
cardiac outcomes among men in this study, unless use
of different treatmentswas also associatedwith severity
of disease. It is possible that practices that contribute
data to clinical databases, such as the one used in this
study, provide a different level of care from those that
do not. If so, this could have important implications for
the generalisability of our results. Finally, as with all
studies in which multiple comparisons are made,
some significant findings might have occurred by
chance.
Conclusions
There are important differences in outcome with
angina among certain subgroups. Men have a signifi-
cantly increased likelihood of revascularisation, acute
myocardial infarction, death from ischaemic heart dis-
ease, and all cause mortality.
Linked clinical datasets, such as the one described,
provide important opportunities to study prognosis
after an event quickly and cost effectively. Ideally,
future studies of prognosis after a first episodeof angina
should focus on primary care; include patients who
have been phenotyped after diagnostic tests such as
coronary angiography; be able to look at the effects
of different interventions (such as angioplasty without
stenting, or with conventional stents or drug eluting
stents, and medical treatments); allow for the fre-
quency and severity of angina symptoms and changes
in treatments and risk factor profiles over time.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
The findings of prognostic studies of angina in secondary or tertiary care populations might
not be transferable to primary care, and primary care populations have been insufficiently
researched
In trial populations, the value of percutaneous transluminal coronary angioplasty in people
with angina alone is uncertain
WHAT THIS PAPER ADDS
In patients with angina in primary care there is a significant association between male sex
and subsequent acute myocardial infarction, death related to heart disease, or death from
any cause
Prevention of subsequent acutemyocardial infarction is important in patients diagnosed with
angina to avoid a significantly increased risk of death
Neither coronary artery bypass grafting nor percutaneous transluminal coronary angioplasty
was associated with a significantly reduced five year risk of death among patients with
angina.
Linked primary and secondary care clinical datasets provide an important opportunity to
conduct studies of prognosis quickly and cost effectively
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